Squarepoint Ops LLC Grows Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Squarepoint Ops LLC raised its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 115.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 75,296 shares of the company’s stock after buying an additional 40,369 shares during the period. Squarepoint Ops LLC’s holdings in LifeStance Health Group were worth $370,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. ProShare Advisors LLC boosted its holdings in LifeStance Health Group by 8.5% during the 1st quarter. ProShare Advisors LLC now owns 19,069 shares of the company’s stock valued at $118,000 after acquiring an additional 1,500 shares during the period. Bessemer Group Inc. lifted its holdings in LifeStance Health Group by 43.4% during the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock worth $56,000 after buying an additional 2,768 shares in the last quarter. Victory Capital Management Inc. boosted its position in LifeStance Health Group by 27.0% in the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock valued at $71,000 after buying an additional 3,063 shares during the period. SG Americas Securities LLC grew its stake in shares of LifeStance Health Group by 8.7% in the first quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock worth $277,000 after acquiring an additional 3,600 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of LifeStance Health Group by 12.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company’s stock worth $262,000 after acquiring an additional 4,681 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently commented on the company. UBS Group lowered their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, August 15th. Barclays decreased their price target on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $8.25.

LifeStance Health Group Price Performance

Shares of LFST opened at $6.89 on Friday. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.22 and a quick ratio of 1.22. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $9.20. The stock has a market cap of $2.63 billion, a PE ratio of -14.35 and a beta of 1.24. The firm has a fifty day moving average price of $6.43 and a 200 day moving average price of $6.06.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The business had revenue of $312.30 million during the quarter, compared to the consensus estimate of $305.85 million. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. The business’s quarterly revenue was up 20.3% on a year-over-year basis. During the same period in the previous year, the business earned ($0.13) EPS. As a group, sell-side analysts anticipate that LifeStance Health Group, Inc. will post -0.24 EPS for the current year.

Insider Buying and Selling

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total transaction of $33,089.32. Following the completion of the sale, the insider now directly owns 263,007 shares of the company’s stock, valued at $1,651,683.96. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 6.60% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.